抗ENO1 抗体联合二甲双胍通过靶向肿瘤干细胞逆转人非小细胞肺癌 A549 细胞对西妥昔单抗的抵抗

MLA

张蕙雯, et al. “抗ENO1 抗体联合二甲双胍通过靶向肿瘤干细胞逆转人非小细胞肺癌 A549 细胞对西妥昔单抗的抵抗 (Chinese).” Chinese Journal of Cancer Biotherapy, vol. 28, no. 3, Mar. 2021, pp. 239–46. EBSCOhost, https://doi.org/10.3872/j.issn.1007-385x.2021.03.004.

APA

张蕙雯, 杨婷, 禹卓玥, 孙立新, 刘军, 遇珑, 孙力超, & 冉宇靓. (2021). 抗ENO1 抗体联合二甲双胍通过靶向肿瘤干细胞逆转人非小细胞肺癌 A549 细胞对西妥昔单抗的抵抗 (Chinese). Chinese Journal of Cancer Biotherapy, 28(3), 239–246. https://doi.org/10.3872/j.issn.1007-385x.2021.03.004

Chicago

张蕙雯, 杨婷, 禹卓玥, 孙立新, 刘军, 遇珑, 孙力超, and 冉宇靓. 2021. “抗ENO1 抗体联合二甲双胍通过靶向肿瘤干细胞逆转人非小细胞肺癌 A549 细胞对西妥昔单抗的抵抗 (Chinese).” Chinese Journal of Cancer Biotherapy 28 (3): 239–46. doi:10.3872/j.issn.1007-385x.2021.03.004.